1563PDMagnitude of clinical benefit in trials supporting US Food and Drug Administration (FDA) accelerated approval (AA) and European Medicines Agency (EMA) conditional marketing authorisation (CMA) and subsequent trials supporting conversion to full approval
Borrell Puy, M; Molto Valiente, C; Vokinger, K; Hwang, T; Ocana Fernandez, A; Templeton, A J; Seruga, B; Gich Saladich, I; Barnadas, A; Amir, E; Tibau, A
- 期刊名称Annals of Oncology
- 作者Borrell Puy, M; Molto Valiente, C; Vokinger, K; Hwang, T; Ocana Fernandez, A; Templeton, A J; Seruga, B; Gich Saladich, I; Barnadas, A; Amir, E; Tibau, A
- 卷第29卷
- 印刷ISSN0923-7534
- 电子ISSN1569-8041
- 文件大小80.12KB
- 发表时间2018-10-01
- DOI10.1093/annonc/mdy297.007